Panacea Biotec up 13 pct on US FDA nod for migraine drug
New Delhi [India], Jan 18 (ANI): Shares of Panacea Biotec zoomed over 13 percent intraday on Wednesday as the company received the US drug regulator's nod for a drug.
New Delhi [India], Jan 18 (ANI): Shares of Panacea Biotec zoomed over 13 percent intraday on Wednesday as the company received the US drug regulator's nod for a drug.
What to Read Next
The first day of SEMICON India 2026 saw the government lay out a wider roadmap for the next phase of India's semiconductor programme, with around Rs 1 lakh crore in investment commitments, plans to create close to one lakh jobs and a series of agreements spanning chip manufacturing, materials, packaging, design and talent development.
Read More"The allegation that MDR has been introduced under any external influence is patently false and misleading," the Department said
Read MoreIndia’s semiconductor push is beginning to move into a commercial production phase, with companies expanding local manufacturing, bringing products to market and building domestic supplier networks, according to industry executives at SEMICON India 2026.
Read MoreTata Trusts on Thursday asked Tata Sons to explore all available options other than listing, reiterating their opposition to the public listing of the holding company and stressing the need to preserve the structure of the Tata Group.
Read MoreInitial jobless claims in the United States fell to 196,000 in the week ended September 12, their lowest level since mid-July, according to data released by the US Department of Labor on Thursday, a day after the Federal Reserve raised interest rates by 25 basis points.
Read MoreRelated News
Copyright © aninews.in | All Rights Reserved.